Shanghai Pharmaceuticals Holding Co (SHPMF) Stock Forecast & Price Target

Compare

12 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SHPMF Analyst Ratings

Moderate Buy

3 Buy

0 Hold

1 Sell

Based on 4 analysts giving stock ratings to

Shanghai

Pharmaceuticals Holding Co

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SHPMF Stock 12 Month Forecast

Average Price Target

$1.79

▲(16.23% Upside)

Based on 4 Wall Street analysts offering 12 month price targets for Shanghai Pharmaceuticals Holding Co in the last 3 months. The average price target is $1.79 with a high forecast of $1.93 and a low forecast of $1.52. The average price target represents a 16.23% change from the last price of $1.54.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","2":"$2","0.5":"$0.5","1.5":"$1.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.93,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.79,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.79</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.52,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.52</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,0.5,1,1.5,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Apr<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.54,1.57,1.6,1.63,1.66,1.69,1.72,1.75,1.78,1.81,1.8399999999999999,1.8699999999999999,1.9,{"y":1.93,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.54,1.5592307692307692,1.5784615384615386,1.5976923076923077,1.616923076923077,1.6361538461538463,1.6553846153846155,1.6746153846153846,1.6938461538461538,1.7130769230769232,1.7323076923076923,1.7515384615384617,1.7707692307692309,{"y":1.79,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.54,1.5384615384615385,1.536923076923077,1.5353846153846153,1.5338461538461539,1.5323076923076924,1.5307692307692309,1.5292307692307692,1.5276923076923077,1.5261538461538462,1.5246153846153847,1.523076923076923,1.5215384615384615,{"y":1.52,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.41,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.41,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.41,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.24,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.59,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.48,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.46,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.34,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.45,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.58,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.56,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.56,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.54,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1.93

Average Price Target$1.79

Lowest Price Target$1.52

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

HSBC

Not Ranked

HSBC

$1.55→$1.52

Sell

-1.53%

Downside

Reiterated

11/10/25

HSBC Remains a Sell on Shanghai Pharmaceuticals Holding Co (SHPMF)

Unknown Analyst

Citi

Not Ranked

Citi

$1.82

Buy

18.50%

Upside

Reiterated

11/03/25

Citi Sticks to Their Buy Rating for Shanghai Pharmaceuticals Holding Co (SHPMF)

Unknown Analyst

CICC

Not Ranked

CICC

$1.89

Buy

22.67%

Upside

Reiterated

11/01/25

Unknown Analyst

UBS

Not Ranked

UBS

$1.93

Buy

25.17%

Upside

Reiterated

10/31/25

Unknown Analyst

HSBC

Not Ranked

HSBC

$1.55

Sell

0.97%

Upside

Reiterated

09/08/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

$1.84

Buy

19.33%

Upside

Reiterated

08/29/25

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

$2.18

Buy

41.86%

Upside

Reiterated

07/10/25

Unknown Analyst

Guotai Haitong

Not Ranked

Guotai Haitong

$1.76

Buy

14.57%

Upside

Reiterated

05/06/25

Unknown Analyst

CLSA

Not Ranked

CLSA

$1.77→$1.58

Buy

2.64%

Upside

Reiterated

04/07/25

Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Lowered to HK$12.30 at CLSACLSA analyst John Yung lowered the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$12.30 (from HK$13.80) while maintaining a Outperform (2) rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

HSBC

Not Ranked

HSBC

$1.55→$1.52

Sell

-1.53%

Downside

Reiterated

11/10/25

HSBC Remains a Sell on Shanghai Pharmaceuticals Holding Co (SHPMF)

Unknown Analyst

Citi

Not Ranked

Citi

$1.82

Buy

18.50%

Upside

Reiterated

11/03/25

Citi Sticks to Their Buy Rating for Shanghai Pharmaceuticals Holding Co (SHPMF)

Unknown Analyst

CICC

Not Ranked

CICC

$1.89

Buy

22.67%

Upside

Reiterated

11/01/25

Unknown Analyst

UBS

Not Ranked

UBS

$1.93

Buy

25.17%

Upside

Reiterated

10/31/25

Unknown Analyst

HSBC

Not Ranked

HSBC

$1.55

Sell

0.97%

Upside

Reiterated

09/08/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

$1.84

Buy

19.33%

Upside

Reiterated

08/29/25

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

$2.18

Buy

41.86%

Upside

Reiterated

07/10/25

Unknown Analyst

Guotai Haitong

Not Ranked

Guotai Haitong

$1.76

Buy

14.57%

Upside

Reiterated

05/06/25

Unknown Analyst

CLSA

Not Ranked

CLSA

$1.77→$1.58

Buy

2.64%

Upside

Reiterated

04/07/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Shanghai Pharmaceuticals Holding Co

1 Month

xxx

Success Rate

0/4 ratings generated profit

Average Return

-2.85%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -2.85% per trade.

3 Months

xxx

Success Rate

0/4 ratings generated profit

Average Return

-3.02%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -3.02% per trade.

1 Year

Owen MediportTR | OpenAI - 4o

Success Rate

0/4 ratings generated profit

Average Return

-3.28%

reiterated a buy rating 2 months ago

Copying Owen Mediport's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -3.28% per trade.

2 Years

xxx

Success Rate

0/4 ratings generated profit

Average Return

-3.28%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -3.28% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHPMF Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SHPMF has received 10 Buy Ratings, 0 Hold Ratings, and 2 Sell Ratings. SHPMF average Analyst price target in the past 3 months is 1.79.

Each month's total comprises the sum of three months' worth of ratings.

SHPMF Financial Forecast

SHPMF Earnings Forecast

Next quarter’s earnings estimate for SHPMF is $0.03 with a range of $0.01 to $0.05. The previous quarter’s EPS was $0.03. SHPMF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year SHPMF has Performed in-line its overall industry.

SHPMF Sales Forecast

Next quarter’s sales forecast for SHPMF is $9.48B with a range of $9.36B to $9.61B. The previous quarter’s sales results were $10.32B. SHPMF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year SHPMF has Performed in-line its overall industry.

SHPMF Stock Forecast FAQ

What is SHPMF’s average 12-month price target, according to analysts?

Based on analyst ratings, Shanghai Pharmaceuticals Holding Co Class H’s 12-month average price target is 1.79.

What is SHPMF’s upside potential, based on the analysts’ average price target?

Shanghai Pharmaceuticals Holding Co Class H has 16.23% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SHPMF a Buy, Sell or Hold?

Shanghai Pharmaceuticals Holding Co Class H has a consensus rating of Moderate Buy which is based on 3 buy ratings, 0 hold ratings and 1 sell ratings.

What is Shanghai Pharmaceuticals Holding Co Class H’s price target?

The average price target for Shanghai Pharmaceuticals Holding Co Class H is 1.79. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1.93 ,the lowest forecast is $1.52. The average price target represents 16.23% Increase from the current price of $1.54.

What do analysts say about Shanghai Pharmaceuticals Holding Co Class H?

Shanghai Pharmaceuticals Holding Co Class H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.

How can I buy shares of SHPMF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Shanghai Pharmaceuticals Holding Co (SHPMF) Stock Forecast & Price Target

SHPMF Analyst Ratings

SHPMF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Shanghai Pharmaceuticals Holding Co

SHPMF Analyst Recommendation Trends

SHPMF Financial Forecast

SHPMF Earnings Forecast

SHPMF Sales Forecast

SHPMF Stock Forecast FAQ

Detailed List of Analyst Forecasts